21/09/2016

Biohit Oyj

The first meta-analysis of the scientific studies conducted with GastroPanel® has been completed – the test is accurate for diagnosing atrophic gastritis

21.09.2016 09:30 Biohit Oyj Press Release September 21, 2016 at 09:30 am local time (EEST)
 
The first meta-analysis of the scientific studies conducted with GastroPanel® test has been completed. GastroPanel® is a unique test for diagnosing helicobacter gastritis (infection) and atrophic gastritis developed from it.  Atrophic gastritis, which is usually asymptomatic, can be detected only with GastroPanel® or gastroscopy and biopsy examination. Particularly for this reason, a stomach cancer developed as a result is diagnosed at late stages, when the prognosis is usually very poor.
 
The meta-analysis included systematically all the studies analysing the sensitivity and specificity of GastroPanel® test in diagnosing atrophic gastritis. Although there is variation between individual studies, results of the meta-analysis confirm that GastroPanel® is a sensitive and specific test for detecting atrophic gastritis in both corpus and antrum of the stomach. The scientific report of the meta-analysis has been accepted for publication in Anticancer Research journal (1).

Exhibitor Data Sheet